We are pleased to present two recent Journal of Hematology & Oncology thematic series:
Thematic series
Aims and scope
Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology. Read more.
Articles
-
-
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia
-
Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL
-
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial
-
m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
The Research to this article has been published in Journal of Hematology & Oncology 2019 12:135
-
Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options
-
The effects of β-glucan on human immune and cancer cells
-
The diagnosis and management of NK/T-cell lymphomas
-
Mechanism of action of lenalidomide in hematological malignancies
-
Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers
Editor's quote
"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."
Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology
Experimental Hematology & Oncology
Submit your research to our companion journal, Experimental Hematology & Oncology
-
Official journal of
-
Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
-
- Editorial Board
- Instructions for Editors
- Instructions for authors
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
Speed
41 days to first decision for reviewed manuscripts only
19 days to first decision for all manuscripts
79 days from submission to acceptance
24 days from acceptance to publication
Citation Impact
11.059 - 2-year Impact Factor
8.474 - 5-year Impact Factor
1.923 - Source Normalized Impact per Paper (SNIP)
3.231 - SCImago Journal Rank (SJR)
Usage
982,034 Downloads
845 Altmetric Mentions
On the blog
-
MIRRORS: robotic surgery for advanced ovarian cancer
19 February 2021
-
-
Institutional membership
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).
